Press Releases

September 4 2014

Washington, D.C. (September 4, 2014) – The Biotechnology...

August 6 2014

Survey responses will help inform Prescription Drug User Fee Act VI negotiations

May 9 2014

Bill would strengthen, make permanent critical R&D tax credit

April 9 2014

The House Subcommittee on Capital Markets and Government Sponsored Enterprises held a hearing...

April 7 2014

The EXPIRE Act would extend tax credits that expired at the end of 2013, including...

February 12 2014

Bill would spur capital formation for small public companies

December 19 2013

More than 140 Companies Expected to Present Their Story to Top Public and...

November 13 2013

The Bill will spur capital formation for small public companies

November 6 2013

Bill will encourage investment in growing innovative companies

September 30 2013

NSF-funded companies focused on drug discovery, diagnostics and other platform technologies....

September 11 2013

Speakers will provide fresh insight, investment opportunities in biotech sector.

May 21 2013

CSBI encourages a tax code that promotes economic growth and creates jobs.

May 16 2013

H.R. 701 sets a deadline to complete rule-making on Regulation A reforms.

May 15 2013

H.R. 1952 will stimulate trading for small public companies.

January 8 2013

Small Business Innovation Research grants provide critical support for emerging biotech...

September 25 2012

Bill would stimulate capital formation for small biotech companies.

July 26 2012

The House Subcommittee on Capital Markets held a hearing entitled “The 10th Anniversary...

July 20 2012

New bill will update SEC filing status classifications to ease costly regulatory burdens...

June 6 2012

The report will be released at a Super Session, titled "International Leaders Share Their...

March 27 2012

The JOBS Act will incentivize and encourage capital formation for growing companies, and...

March 20 2012

Buzz of BIO voting available online.

March 8 2012

House passes H.R. 3606, the Jumpstart Our Business Startups (JOBS) Act.

March 6 2012

OncoMed Pharmaceuticals SVP/CFO provided testimony today on behalf of BIO at a Senate...

January 18 2012

Fireside Chats to focus on biopharma R&D and corporate strategy.

December 19 2011

Extension of cellulosic biofuel tax credits now and eligibility for algae biofuels are needed...

December 16 2011

Grants will provide critical funding to small emerging biotechnology companies working on...

December 13 2011

Small Business Innovation Research (SBIR) grants provide critical funding for the development...

December 6 2011

Washington, DC (December 6, 2011) – The Biotechnology Industry Organization (BIO)...

November 16 2011

"The most important return on investment from this initiative would be the creation of...

October 13 2011

BIO President and CEO Jim Greenwood released the following statement on the Obama...

October 11 2011

BIO Investor Forum will be held October 25 – 26 in San Francisco, CA

...

October 6 2011

BIO Investor Forum will be held October 25 – 26 in San Francisco, CA 

September 19 2011

  The Biotechnology Industry Organization (BIO) today announced the preliminary set...

September 9 2011

BIO President and CEO Jim Greenwood released the following statement on President Obama’...

September 6 2011

The Biotechnology Industry Organization (BIO) announced the keynote speakers for the BIO India...

July 26 2011

BIO applauded Secretary of Agriculture Tom Vilsack’s announcement of four new BCAP project areas...

May 4 2011

The Biotechnology Industry Organization (BIO) announced today its selection of Representative...

April 7 2011

Today, the House Subcommittee on Healthcare and Technology will hold a hearing on The Creating...

February 14 2011

The study is expected to inform and improve communications between biotech executives,...

February 11 2011

BIO announces that President and CEO James C. Greenwood will ring the closing bell at The...

February 11 2011

According to a new survey of CEOs of small biotech firms that received Therapeutic Discovery...

February 9 2011

BIO announces that former Senator John B. Breaux (D-LA), former Member, Senate Finance...

January 20 2011

BIO thanks Secretary of Agriculture Tom Vilsack for his leadership on biofuels...

January 10 2011

Hosted by BIO, the exclusive partnering forum brings together U.S. and European drug...

January 3 2011

The 2011 BIO International Convention will highlight the latest trends and the newest...

December 11 2009

BIO commends the House of Representatives for including provisions intended to ease small...

June 26 2007

Today, the House Science and Technology Committee’s Technology and Innovation Subcommittee will...

June 6 2007

The changes proposed by the Securities and Exchange Commission (SEC) and the Public Companies...

April 18 2007

BIO reiterates support as Senate Small Business Committee considers changes.

February 28 2007

BIO thanks the Bush administration for taking dramatic new steps to transform biotech...

December 13 2006

BIO President and CEO Jim Greenwood today commented on reports that the Securities and Exchange...

September 20 2006

The Milken Institute study released today entitled “Mind-to-Market: A Global Analysis of...

May 30 2002

The Biotechnology Industry Organization’s (BIO) annual meeting, BIO 2002 in Toronto,...

April 29 2014
Chairperson Mikulski, Ranking Member Shelby, Members of the Committee, thank you for the opportunity to provide you with written testimony on the extremely important topic of driving innovation through federal investments.
November 6 2013
On behalf of the BIO and its 1,100 members, I am writing in strong support of your Start-up Jobs and Innovation Act. I want to thank you for introducing this important legislation, which will spur investment in small biotech companies and other innovative businesses.
July 10 2013
A healthy public market is key to the success of the biotech industry, as growing innovators often turn to an IPO to fund late-stage clinical trials.
July 26 2012
Jeffrey S. Hatfield, President and Chief Executive Officer of Vitae Pharmaceuticals, testified on behalf of BIO about the 10th anniversary of the Sarbanes-Oxley Act.
March 16 2012
On behalf of BIO and its more than 1,100 members, Jim Greenwood submitted a letter to Senate Majority Leader Harry Reid and Minority Leader Mitch McConnell in strong support of H.R. 3606, the Jumpstart Our Business Startups (JOBS) Act.
September 17 2014
Legislation aimed at enhancing capital access and creating jobs
September 4 2014
Washington, D.C. (September 4, 2014) – The Biotechnology Industry Organization (BIO) is pleased to announce the winners of the 2014 BIO Investor Forum Buzz of BIO contest, which recognizes highly innovative companies in the biotech sector. Taking place October 7-8, 2014 at the Palace Hotel in San Francisco, California, the 13th Annual BIO Investor Forum will focus on investment opportunities for early stage and established private companies as well as emerging public companies.
August 6 2014
Survey responses will help inform Prescription Drug User Fee Act VI negotiations
May 9 2014
Bill would strengthen, make permanent critical R&D tax credit
April 9 2014
The House Subcommittee on Capital Markets and Government Sponsored Enterprises held a hearing titled “Legislative Proposals to Enhance Capital Formation for Small and Emerging Growth Companies.” Brian Hahn, Chief Financial Officer of GlycoMimetics, Inc. presented testimony at the hearing on enhancements to the capital markets that can increase access to investors and decrease unnecessary regulatory burdens for emerging biotech companies trading on the public market.